Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication

Saudi Medical Journal

Volumn 24, Issue 4, 2003, Pages 347-351

  Ghadban, Wisam K ^a   Zirie, Mahmoud A ^a   Al Khateeb, Daoud A ^b   Jayyousi, Amin A ^a   Mobayedh, Hassan M ^a   El Aloosy, Ahmed S ^b  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b HAMAD GENERAL HOSPITAL   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; IODINE 131; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THYROTROPIN; THYROXINE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; COLON CANCER; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG UPTAKE; ENDOCRINE OPHTHALMOPATHY; FEMALE; GENDER; GROUPS BY AGE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NODULAR GOITER; QATAR; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; THYROID CANCER; TOXIC GOITER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTITHYROID AGENTS; CHILD; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0038192465     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Franklyn JA. Drug therapy: The management of Hyperthyroidism. N Engl J Med 1994; 330: 1731-1738.
2. Husymans DA, Hermus AR, Corstens FH, Kloppenborg PW. Long-term results of two schedules of radioiodine treatment for toxic multinodular goiter. Eur J Nucl Med 1993; 20: 1056-1062.
3. Andrade VA, Gross JL, Maia AL. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. J Clin Endocrinol Metab 2001; 86: 3488-3493.
4. 131 in hyperthyroidism. J Clin Endocrinol Metab 1998; 83: 685-687.
5. Wartofsky L. Radioactive Iodine vs. Antithyroid drugs in management of graves' Disease. Thyroid Workshop "Current Concepts and Controversies VII". Atlanta (GA): American Thyroid Association and American Association of Clinical Endocrinologists; 1999. p. 38-44.
6. Tamai H, Kasagi K, Takaichi Y, Takamatsu J, Komaki G, Matsubayashi S et al. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: Clinical immunological and histological findings in 26 patients. J Clin Endocrinol 1989; 69: 49-53.
7. 131I) therapy and the incidence of hypothyroidism. Ann Acad Med Singapore 1997; 26: 128-131.
8. Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SC, Franklyn JA. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab 2000; 85: 1038-1042.
9. Nordyke RA, Gilbert FI Jr. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 1991; 32: 411-416.
10. Rapoport B, Caplan R, DeGroot LJ. Low-dose sodium iodine 131 therapy in Graves' disease. JAMA 1973; 224: 1610-1611.
11. Goolden AW, Stewart JS. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis. Clin Endocrinol 1986; 24: 217-222.
12. Peters H, Fisher C, Bogner U, Reiners C, Schleusener H. Treatment of Graves' hyperthyroidism with radioiodine: Results of a prospective randomized study. Thyroid 1997; 7: 247-251.
13. Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 2001; 86: 3611-3617.
14. 131I therapy. Br Med J 1960; 1: 151-154.
15. 131I) therapy. Eur J Nuc Med 1984; 9: 464-466.
16. Reynolds LR, Kotchen TA. Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease. Arch Intern Med 1979; 139: 651-653.
17. Einhorn J, Saterborg N. Antithyroid drugs in iodine 131 therapy of hyperthyroidism. Acta Radiol 1962; 58: 161-167.
18. 131I therapy for Graves' disease. N Engl J Med 1984; 311: 426-432.
19. Marcocci C, Gianchecchi D, Masini I, Golia F, Ceccarelli C, Bracci E et al. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 1990; 13: 513-520.
20. Hancock LD, Tuttle RM, Lemar H, Bauman J, Patience T. The effect of propylthioracil on subsequent radioactive iodine therapy in Graves' disease. Clin Endocrinol (Oxf) 1997; 47: 425-430.
21. Tuttle RM, Patience T, Budd S. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 1995; 5: 243-247.
22. Sabri O, Zimny M, Schulz G, Schrechenberger M, Reinartz P, Willmes K. Success rate of radioiodine therapy in Grave's disease: the influence of thyrostatic medication. The Journal of Clinical Endocrinology Metabolism 1999; 84: 1229-1233.
23. Sridama V, DeGroot LJ. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 1989; 87: 70-73.
24. Gwinup G, Elias AN, Ascher MS. Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA 1982; 247: 2135-2138.
25. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA et al. Chronology of Graves' ophthalmopathy in an incident cohort. Am J Ophthalmol 1996; 121: 426-434.
26. Bartelena L, Marcocci C, Bogazzi F, Mannetti L, Tanda ML, Dell'unto E et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998; 338: 73-78.
27. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 1992; 326: 1733-1738.
28. Tallstedt L, Lundell G, Blomgren H, Bring J. Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment. Eur J Endocrinol 1994; 130: 494-497.
29. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle B. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 1998; 338: 712-718.
30. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle B. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999; 9170: 2111-2115.